SPCS1
gene geneOn this page
Also known as SPC12HSPC033YJR010C-ASPC1
Summary
SPCS1 (signal peptidase complex subunit 1, HGNC:23401) is a protein-coding gene on chromosome 3p21.1, encoding Signal peptidase complex subunit 1 (Q9Y6A9). Component of the signal peptidase complex (SPC) which catalyzes the cleavage of N-terminal signal sequences from nascent proteins as they are translocated into the lumen of the endoplasmic reticulum.
Predicted to enable ribosome binding activity. Involved in signal peptide processing; viral protein processing; and virion assembly. Located in endoplasmic reticulum membrane. Part of signal peptidase complex.
Source: NCBI Gene 28972 — RefSeq curated summary.
At a glance
- GWAS associations: 15
- Clinical variants (ClinVar): 39 total
- MANE Select transcript:
NM_014041
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23401 |
| Approved symbol | SPCS1 |
| Name | signal peptidase complex subunit 1 |
| Location | 3p21.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | SPC12, HSPC033, YJR010C-A, SPC1 |
| Ensembl gene | ENSG00000114902 |
| Ensembl biotype | protein_coding |
| OMIM | 610358 |
| Entrez | 28972 |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 5 protein_coding, 2 retained_intron
ENST00000233025, ENST00000423431, ENST00000448693, ENST00000474945, ENST00000619898, ENST00000858694, ENST00000918254
RefSeq mRNA: 1 — MANE Select: NM_014041
NM_014041
CCDS: CCDS33769
Canonical transcript exons
ENST00000619898 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003340594 | 52706106 | 52706282 |
| ENSE00003463864 | 52706793 | 52706879 |
| ENSE00003498706 | 52706644 | 52706703 |
| ENSE00003718485 | 52707687 | 52711148 |
Expression profiles
Bgee: expression breadth ubiquitous, 294 present calls, max score 99.62.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 189.7995 / max 1450.0248, expressed in 1826 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 36892 | 188.8109 | 1826 |
| 36891 | 0.9886 | 561 |
Top tissues by expression
294 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 99.62 | gold quality |
| male germ cell | CL:0000015 | 99.40 | gold quality |
| parotid gland | UBERON:0001831 | 99.32 | gold quality |
| tibia | UBERON:0000979 | 99.24 | gold quality |
| adult organism | UBERON:0007023 | 99.21 | gold quality |
| jejunal mucosa | UBERON:0000399 | 99.02 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 98.98 | gold quality |
| seminal vesicle | UBERON:0000998 | 98.97 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 98.97 | gold quality |
| eye | UBERON:0000970 | 98.90 | gold quality |
| bronchial epithelial cell | CL:0002328 | 98.81 | gold quality |
| type B pancreatic cell | CL:0000169 | 98.75 | gold quality |
| epithelium of esophagus | UBERON:0001976 | 98.75 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 98.74 | gold quality |
| retina | UBERON:0000966 | 98.71 | gold quality |
| body of pancreas | UBERON:0001150 | 98.63 | gold quality |
| corpus epididymis | UBERON:0004359 | 98.63 | gold quality |
| secondary oocyte | CL:0000655 | 98.56 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 98.49 | gold quality |
| oral cavity | UBERON:0000167 | 98.48 | gold quality |
| right testis | UBERON:0004534 | 98.44 | gold quality |
| left testis | UBERON:0004533 | 98.40 | gold quality |
| oocyte | CL:0000023 | 98.39 | gold quality |
| epithelium of bronchus | UBERON:0002031 | 98.34 | gold quality |
| bronchus | UBERON:0002185 | 98.31 | gold quality |
| colonic mucosa | UBERON:0000317 | 98.25 | gold quality |
| nephron tubule | UBERON:0001231 | 98.24 | gold quality |
| trabecular bone tissue | UBERON:0002483 | 98.21 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 98.20 | gold quality |
| pancreas | UBERON:0001264 | 98.16 | gold quality |
Single-cell (SCXA)
Detected in 21 experiment(s), a significant marker in 18.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-88 | yes | 78.32 |
| E-HCAD-4 | yes | 67.01 |
| E-CURD-46 | yes | 44.87 |
| E-HCAD-1 | yes | 42.53 |
| E-MTAB-8410 | yes | 40.18 |
| E-MTAB-7316 | yes | 40.04 |
| E-CURD-122 | yes | 36.93 |
| E-HCAD-11 | yes | 19.92 |
| E-MTAB-6701 | yes | 17.48 |
| E-MTAB-8142 | yes | 16.23 |
| E-CURD-112 | yes | 15.32 |
| E-MTAB-9467 | yes | 14.89 |
| E-MTAB-10042 | yes | 13.63 |
| E-MTAB-8498 | yes | 13.45 |
| E-GEOD-137537 | yes | 13.02 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
35 targeting SPCS1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-146A-5P | 99.96 | 68.93 | 988 |
| HSA-MIR-146B-5P | 99.96 | 69.13 | 977 |
| HSA-MIR-7153-5P | 99.94 | 68.89 | 1006 |
| HSA-MIR-335-3P | 99.93 | 73.36 | 4958 |
| HSA-MIR-5680 | 99.91 | 69.83 | 3421 |
| HSA-MIR-5582-3P | 99.86 | 72.48 | 4221 |
| HSA-MIR-548AR-3P | 99.85 | 71.26 | 3889 |
| HSA-MIR-4766-5P | 99.75 | 69.23 | 2662 |
| HSA-MIR-378G | 99.71 | 64.90 | 1106 |
| HSA-MIR-4729 | 99.69 | 72.18 | 4233 |
| HSA-MIR-1284 | 99.67 | 73.56 | 1353 |
| HSA-MIR-4261 | 99.59 | 70.30 | 3415 |
| HSA-MIR-451B | 99.55 | 68.28 | 1380 |
| HSA-MIR-147B-5P | 99.45 | 70.62 | 2432 |
| HSA-MIR-183-3P | 99.41 | 69.41 | 1598 |
| HSA-MIR-4311 | 99.31 | 70.47 | 3041 |
| HSA-MIR-3925-5P | 99.21 | 67.90 | 1466 |
| HSA-MIR-4709-3P | 98.88 | 68.04 | 1594 |
| HSA-MIR-6889-3P | 98.84 | 67.35 | 1198 |
| HSA-MIR-606 | 98.72 | 67.34 | 960 |
| HSA-MIR-6501-3P | 98.71 | 67.45 | 1480 |
| HSA-MIR-1-5P | 98.70 | 68.66 | 1017 |
| HSA-MIR-6529-3P | 98.68 | 66.76 | 1020 |
| HSA-MIR-7155-5P | 98.65 | 66.14 | 1290 |
| HSA-MIR-1285-5P | 98.01 | 68.71 | 779 |
| HSA-MIR-3665 | 97.73 | 65.08 | 975 |
| HSA-MIR-3622A-3P | 97.06 | 66.43 | 1000 |
| HSA-MIR-3622B-3P | 96.82 | 66.36 | 988 |
Literature-anchored findings (GeneRIF, showing 4)
- SPCS1 plays a key role in the formation of the membrane-associated NS2-E2 complex via its interaction with NS2 and E2, which leads to a coordinating interaction between the structural and non-structural proteins (PMID:24009510)
- cis-acting regulatory polymorphisms acting on GNL3 and SPCS1 contribute to the OA association signal at chromosome 3p21, and these genes therefore merit further investigation. (PMID:24886551)
- the results demonstrate that SPCS1 affects viral replication by interacting with NS2B, thereby influencing the posttranslational processing of Japanese Encephalitis Virus proteins and the assembly of virions. (PMID:29593046)
- SPCS1-Dependent E2-p7 processing determines HCV Assembly efficiency. (PMID:35130329)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | spcs1 | ENSDARG00000059298 |
| mus_musculus | Spcs1 | ENSMUSG00000021917 |
| rattus_norvegicus | Spcs1 | ENSRNOG00000018075 |
| drosophila_melanogaster | Spase12 | FBGN0040623 |
| caenorhabditis_elegans | spcs-1 | WBGENE00016395 |
Protein
Protein identifiers
Signal peptidase complex subunit 1 — Q9Y6A9 (reviewed: Q9Y6A9)
Alternative names: Microsomal signal peptidase 12 kDa subunit
All UniProt accessions (3): Q9Y6A9, A0A5F9YFS9, C9JBL1
UniProt curated annotations — full annotation on UniProt →
Function. Component of the signal peptidase complex (SPC) which catalyzes the cleavage of N-terminal signal sequences from nascent proteins as they are translocated into the lumen of the endoplasmic reticulum. Dispensable for SPC enzymatic activity. (Microbial infection) Required for the post-translational processing of proteins involved in virion assembly and secretion from flaviviruses such as West Nile virus (WNV), Japanese encephalitis virus (JEV), Dengue virus type 2 (DENV-2), Yellow Fever virus (YFV), Zika virus (ZIKV) and hepatitis C virus (HCV). Plays a key role in the post-translational processing of flaviviral structural proteins prM, E, and NS1. In HCV, it is involved in virion assembly where it promotes the interaction between HCV virus proteins NS2 and E2.
Subunit / interactions. Component of the signal peptidase complex paralog A (SPC-A) composed of a catalytic subunit SEC11A and three accessory subunits SPCS1, SPCS2 and SPCS3. Component of the signal peptidase complex paralog C (SPC-C) composed of a catalytic subunit SEC11C and three accessory subunits SPCS1, SPCS2 and SPCS3. Within the complex, interacts with SPCS2 and SPCS3. The complex induces a local thinning of the ER membrane which is used to measure the length of the signal peptide (SP) h-region of protein substrates. This ensures the selectivity of the complex towards h-regions shorter than 18-20 amino acids. (Microbial infection) Interacts with hepatitis C virus (HCV) proteins NS2 and E2. Interacts with NS2B from Japanese encephalitis virus (JEV), West Nile virus (WNV), and Zika virus (ZIKV).
Subcellular location. Endoplasmic reticulum membrane.
Post-translational modifications. May be phosphorylated.
Similarity. Belongs to the SPCS1 family.
RefSeq proteins (1): NP_054760* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR009542 | Spc1/SPCS1 | Family |
Pfam: PF06645
UniProt features (12 total): topological domain 3, sequence conflict 3, region of interest 3, transmembrane region 2, chain 1
Structure
Experimental structures (PDB)
2 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 7P2P | ELECTRON MICROSCOPY | 4.9 |
| 7P2Q | ELECTRON MICROSCOPY | 4.9 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9Y6A9-F1 | 64.40 | 0.19 |
Function
Pathways and Gene Ontology
Reactome pathways
16 pathways
| ID | Pathway |
|---|---|
| R-HSA-1799339 | SRP-dependent cotranslational protein targeting to membrane |
| R-HSA-381771 | Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) |
| R-HSA-400511 | Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
| R-HSA-422085 | Synthesis, secretion, and deacylation of Ghrelin |
| R-HSA-9768727 | Regulation of CDH1 posttranslational processing and trafficking to plasma membrane |
| R-HSA-9828806 | Maturation of hRSV A proteins |
| R-HSA-9918432 | Maturation of DENV proteins |
| R-HSA-1643685 | Disease |
| R-HSA-2980736 | Peptide hormone metabolism |
| R-HSA-392499 | Metabolism of proteins |
| R-HSA-400508 | Incretin synthesis, secretion, and inactivation |
| R-HSA-5663205 | Infectious disease |
| R-HSA-72766 | Translation |
| R-HSA-9820952 | Respiratory Syncytial Virus Infection Pathway |
| R-HSA-9820965 | Respiratory syncytial virus (RSV) genome replication, transcription and translation |
| R-HSA-9824446 | Viral Infection Pathways |
MSigDB gene sets: 148 (showing top):
GCANCTGNY_MYOD_Q6, GOBP_PROTEIN_TARGETING, GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ENDOPLASMIC_RETICULUM, GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ORGANELLE, CAGCTG_AP4_Q5, REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS, FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN, GOBP_PROTEIN_MATURATION, GOBP_VIRAL_LIFE_CYCLE, GOBP_VIRION_ASSEMBLY, MORI_PLASMA_CELL_UP, E12_Q6, ACEVEDO_LIVER_CANCER_UP, GOBP_SIGNAL_PEPTIDE_PROCESSING, GOCC_MEMBRANE_PROTEIN_COMPLEX
GO Biological Process (5): obsolete signal peptide processing (GO:0006465), proteolysis (GO:0006508), virion assembly (GO:0019068), viral protein processing (GO:0019082), protein targeting to ER (GO:0045047)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (4): signal peptidase complex (GO:0005787), endoplasmic reticulum membrane (GO:0005789), endoplasmic reticulum (GO:0005783), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-11 pathways:
| Category | Pathways |
|---|---|
| Incretin synthesis, secretion, and inactivation | 2 |
| Peptide hormone metabolism | 2 |
| Metabolism of proteins | 2 |
| Translation | 1 |
| Regulation of CDH1 Expression and Function | 1 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | 1 |
| Dengue Virus Genome Translation and Replication | 1 |
| Disease | 1 |
| Viral Infection Pathways | 1 |
| Respiratory Syncytial Virus Infection Pathway | 1 |
| Infectious disease | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| viral process | 2 |
| protein metabolic process | 1 |
| viral life cycle | 1 |
| viral gene expression | 1 |
| protein targeting | 1 |
| establishment of protein localization to endoplasmic reticulum | 1 |
| binding | 1 |
| endoplasmic reticulum membrane | 1 |
| membrane protein complex | 1 |
| endoplasmic reticulum protein-containing complex | 1 |
| serine-type endopeptidase complex | 1 |
| organelle membrane | 1 |
| nuclear outer membrane-endoplasmic reticulum membrane network | 1 |
| endoplasmic reticulum subcompartment | 1 |
| cytoplasm | 1 |
| endomembrane system | 1 |
| intracellular membrane-bounded organelle | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
1376 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SPCS1 | SPCS2 | Q15005 | 993 |
| SPCS1 | SPCS3 | P12280 | 876 |
| SPCS1 | H0YNG3 | H0YNG3 | 840 |
| SPCS1 | SEC11C | Q9BY50 | 727 |
| SPCS1 | SRP19 | P09132 | 573 |
| SPCS1 | SRP9 | P49458 | 570 |
| SPCS1 | GLT8D1 | Q68CQ7 | 548 |
| SPCS1 | SEC63 | Q9UGP8 | 530 |
| SPCS1 | PCSK2 | P16519 | 507 |
| SPCS1 | SRP68 | Q9UHB9 | 491 |
| SPCS1 | SRPRB | Q9Y5M8 | 486 |
| SPCS1 | SEC61G | P38384 | 483 |
| SPCS1 | SRP54 | P13624 | 473 |
| SPCS1 | SRP72 | O76094 | 472 |
| SPCS1 | SEC61B | P38390 | 462 |
IntAct
110 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SEC11C | SPCS3 | psi-mi:“MI:0914”(association) | 0.820 |
| SEC11C | SPCS3 | psi-mi:“MI:0915”(physical association) | 0.820 |
| SEC11A | SPCS3 | psi-mi:“MI:0914”(association) | 0.770 |
| SEC11A | SPCS3 | psi-mi:“MI:0915”(physical association) | 0.770 |
| GPC1 | HADHB | psi-mi:“MI:0914”(association) | 0.740 |
| EMC4 | EMC8 | psi-mi:“MI:0914”(association) | 0.640 |
| TOMM22 | XRCC3 | psi-mi:“MI:0914”(association) | 0.640 |
| SPCS1 | psi-mi:“MI:0915”(physical association) | 0.630 | |
| SPCS1 | psi-mi:“MI:0915”(physical association) | 0.630 | |
| SPCS1 | psi-mi:“MI:2364”(proximity) | 0.630 | |
| MOXD1 | GPAA1 | psi-mi:“MI:0914”(association) | 0.620 |
| SPCS1 | psi-mi:“MI:2364”(proximity) | 0.600 | |
| SPCS1 | psi-mi:“MI:0915”(physical association) | 0.600 | |
| SPCS1 | psi-mi:“MI:0914”(association) | 0.600 | |
| HYAL4 | GAPDHS | psi-mi:“MI:0914”(association) | 0.560 |
| MGAT4C | GXYLT2 | psi-mi:“MI:0914”(association) | 0.530 |
| SSMEM1 | NDUFA7 | psi-mi:“MI:0914”(association) | 0.530 |
| SEC11C | APOM | psi-mi:“MI:0914”(association) | 0.530 |
| TSPAN5 | SC5D | psi-mi:“MI:0914”(association) | 0.530 |
BioGRID (175): SPCS1 (Affinity Capture-MS), SPCS1 (Affinity Capture-MS), SPCS1 (Affinity Capture-MS), SPCS1 (Affinity Capture-MS), SPCS1 (Affinity Capture-MS), SPCS1 (Affinity Capture-MS), SPCS1 (Affinity Capture-RNA), SPCS1 (Proximity Label-MS), SPCS1 (Proximity Label-MS), SPCS1 (Affinity Capture-MS), SPCS1 (Affinity Capture-MS), SPCS1 (Affinity Capture-MS), SPCS1 (Affinity Capture-MS), SPCS1 (Affinity Capture-MS), SPCS1 (Affinity Capture-MS)
ESM2 similar proteins: B6H6F3, B8NLZ3, C8VDQ4, E5DG73, G4NEB8, O14448, O42794, O54992, O59922, O95259, P0CW19, P0CW20, P25908, P28348, P32023, P52959, P86244, P93025, Q01386, Q03043, Q0U822, Q14123, Q2QYY8, Q2RBR1, Q2UPB6, Q4IJ84, Q4WCV3, Q4WPU8, Q4WQL0, Q4X1A8, Q5RF96, Q5ZKK1, Q60603, Q63421, Q64338, Q6DC61, Q7S1P9, Q7TX80, Q86ZN7, Q8INB9
Diamond homologs: B0FWK4, O44953, P83362, Q3T134, Q54Y83, Q5RF96, Q61CQ8, Q944J0, Q9D958, Q9VAL0, Q9Y6A9
SIGNOR signaling
2 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| SPCS1 | “form complex” | “Signal peptidase complex, SEC11C variant” | binding |
| SPCS1 | “form complex” | “Signal peptidase complex, SEC11A variant” | binding |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 125 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Synthesis, secretion, and deacylation of Ghrelin | 5 | 32.3× | 6e-05 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | 5 | 18.1× | 3e-04 |
| Maturation of DENV proteins | 6 | 13.6× | 2e-04 |
| Post-translational modification: synthesis of GPI-anchored proteins | 5 | 9.0× | 3e-03 |
| Asparagine N-linked glycosylation | 7 | 4.5× | 7e-03 |
| Viral Infection Pathways | 10 | 3.3× | 7e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
39 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 26 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
581 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 3:52706684:G:T | donor_gain | 1.0000 |
| 3:52706699:CTGCA:C | donor_gain | 1.0000 |
| 3:52706700:TGCA:T | donor_gain | 1.0000 |
| 3:52706700:TGCAG:T | donor_loss | 1.0000 |
| 3:52706701:GCA:G | donor_gain | 1.0000 |
| 3:52706701:GCAG:G | donor_gain | 1.0000 |
| 3:52706702:CA:C | donor_gain | 1.0000 |
| 3:52706703:AGT:A | donor_loss | 1.0000 |
| 3:52706704:G:GG | donor_gain | 1.0000 |
| 3:52706704:GTA:G | donor_loss | 1.0000 |
| 3:52706792:GATA:G | acceptor_gain | 1.0000 |
| 3:52707679:T:TA | acceptor_gain | 1.0000 |
| 3:52705881:A:AC | donor_gain | 0.9900 |
| 3:52705882:C:CC | donor_gain | 0.9900 |
| 3:52705950:T:TA | donor_gain | 0.9900 |
| 3:52705950:TC:T | donor_gain | 0.9900 |
| 3:52706175:GTCCT:G | donor_gain | 0.9900 |
| 3:52706176:TCCTT:T | donor_gain | 0.9900 |
| 3:52706493:G:GT | donor_gain | 0.9900 |
| 3:52706493:G:T | donor_gain | 0.9900 |
| 3:52706521:GCCCT:G | donor_gain | 0.9900 |
| 3:52706705:TAA:T | donor_loss | 0.9900 |
| 3:52706706:AAG:A | donor_loss | 0.9900 |
| 3:52706791:A:AG | acceptor_gain | 0.9900 |
| 3:52706792:G:GG | acceptor_gain | 0.9900 |
| 3:52706875:GTTTG:G | donor_gain | 0.9900 |
| 3:52707680:G:A | acceptor_gain | 0.9900 |
| 3:52707686:GCT:G | acceptor_gain | 0.9900 |
| 3:52705446:CA:C | donor_gain | 0.9800 |
| 3:52705929:A:C | donor_gain | 0.9800 |
AlphaMissense
663 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 3:52706658:G:C | Q84H | 0.999 |
| 3:52706658:G:T | Q84H | 0.999 |
| 3:52706799:G:A | G102R | 0.999 |
| 3:52706799:G:C | G102R | 0.999 |
| 3:52706800:G:A | G102E | 0.999 |
| 3:52706811:G:T | G106W | 0.999 |
| 3:52706812:G:A | G106E | 0.999 |
| 3:52706874:T:C | C127R | 0.999 |
| 3:52707702:T:A | W134R | 0.999 |
| 3:52707702:T:C | W134R | 0.999 |
| 3:52707732:T:A | W144R | 0.999 |
| 3:52707732:T:C | W144R | 0.999 |
| 3:52707734:G:C | W144C | 0.999 |
| 3:52707734:G:T | W144C | 0.999 |
| 3:52706653:G:C | G83R | 0.998 |
| 3:52706811:G:A | G106R | 0.998 |
| 3:52706811:G:C | G106R | 0.998 |
| 3:52706842:T:A | V116D | 0.998 |
| 3:52706860:G:A | G122E | 0.998 |
| 3:52706653:G:T | G83C | 0.997 |
| 3:52706654:G:T | G83V | 0.997 |
| 3:52706702:C:A | A99E | 0.997 |
| 3:52706812:G:T | G106V | 0.997 |
| 3:52706830:T:G | F112C | 0.997 |
| 3:52706848:T:A | I118K | 0.997 |
| 3:52706859:G:A | G122R | 0.997 |
| 3:52706859:G:C | G122R | 0.997 |
| 3:52707711:T:G | Y137D | 0.997 |
| 3:52707733:G:C | W144S | 0.997 |
| 3:52706644:G:C | D80H | 0.996 |
dbSNP variants (sampled 300 via entrez): RS1000296187 (3:52710439 C>CAAAG), RS1000579401 (3:52705405 G>A), RS1000688759 (3:52704190 G>A), RS1000786301 (3:52710618 C>T), RS1000880404 (3:52704294 A>C), RS1000922142 (3:52711024 G>A), RS1001421654 (3:52710899 T>C), RS1001990771 (3:52706064 AC>A), RS1002005160 (3:52710257 C>A,G,T), RS1002048634 (3:52705059 G>C), RS1002078693 (3:52710047 A>G), RS1002695285 (3:52706940 G>C,T), RS1002810248 (3:52707283 C>A,T), RS1003655158 (3:52707192 G>A,C), RS1003702405 (3:52708715 A>C)
Disease associations
OMIM: gene MIM:610358 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
15 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001241_15 | Bipolar disorder | 2.000000e-06 |
| GCST002149_14 | Schizophrenia | 1.000000e-08 |
| GCST002539_48 | Schizophrenia | 4.000000e-11 |
| GCST004521_123 | Autism spectrum disorder or schizophrenia | 3.000000e-12 |
| GCST004521_201 | Autism spectrum disorder or schizophrenia | 4.000000e-08 |
| GCST004521_259 | Autism spectrum disorder or schizophrenia | 6.000000e-09 |
| GCST004946_141 | Schizophrenia | 5.000000e-13 |
| GCST006803_55 | Schizophrenia | 1.000000e-11 |
| GCST006950_53 | Feeling worry | 4.000000e-11 |
| GCST008103_3 | Bipolar disorder | 7.000000e-11 |
| GCST010698_14 | Subcortical volume (min-P) | 8.000000e-09 |
| GCST010699_73 | Brain morphology (min-P) | 1.000000e-18 |
| GCST010701_137 | Cortical surface area (MOSTest) | 8.000000e-10 |
| GCST010702_70 | Subcortical volume (MOSTest) | 2.000000e-11 |
| GCST010703_327 | Brain morphology (MOSTest) | 1.000000e-10 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0009589 | worry measurement |
| EFO:0004346 | neuroimaging measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
21 total (human), top 21 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | increases expression, affects cotreatment | 2 |
| bisphenol F | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| sodium arsenite | affects cotreatment, increases abundance, increases expression | 1 |
| manganese chloride | increases abundance, increases expression, affects cotreatment | 1 |
| chloropicrin | decreases expression | 1 |
| K 7174 | decreases expression | 1 |
| bisphenol B | increases expression | 1 |
| bisphenol S | increases expression | 1 |
| bisphenol AF | increases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Arsenic | affects cotreatment, increases abundance, increases expression | 1 |
| Dexamethasone | affects cotreatment, increases expression | 1 |
| Indomethacin | affects cotreatment, increases expression | 1 |
| Ivermectin | decreases expression | 1 |
| Manganese | increases abundance, increases expression, affects cotreatment | 1 |
| Smoke | decreases expression | 1 |
| Thiram | decreases expression | 1 |
| 1-Methyl-3-isobutylxanthine | affects cotreatment, increases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_B3I1 | Abcam HEK293T SPCS1 KO | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.